Hospital
Knox Hospital Company LLC
Knox Hospital Company LLC was paid $4.90M by Medicaid between Jan 2018 and Nov 2024, across 84 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.
33Billing provider infoKNOX HOSPITAL COMPANY LLC
KNOX, IN 46534
KNOX, IN 46534
33aNPI1679948319assigned 12/07/2015
33bProvider typeRural Acute Care Hospital
28Total paid$4.90M
24GClaims131,852
24DCodes billed84
24AFirst – last monthJan 2018 – Nov 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,502 | $254K | |
| 2019 | 20,344 | $509K | |
| 2020 | 11,687 | $357K | |
| 2021 | 16,250 | $754K | |
| 2022 | 23,628 | $1.14M | |
| 2023 | 22,858 | $1.13M | |
| 2024incomplete | 11,583 | $750K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 44% | 14,493 | 11,837 | $2.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 8,241 | 6,241 | $1.12M |
| 71045 | Radiologic examination, chest; single view | 7.7% | 3,989 | 2,934 | $377K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.7% | 2,287 | 1,657 | $230K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 3,376 | 2,449 | $150K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 883 | 763 | $124K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.1% | 1,822 | 1,391 | $104K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 340 | 241 | $69K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 2,859 | 2,246 | $67K |
| 80053 | Comprehensive metabolic panel | 1.3% | 13,160 | 9,754 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 16,235 | 11,817 | $55K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 561 | 144 | $52K |
72 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 366 | $37K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,586 | $32K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,926 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,702 | $22K |
| 80050 | General health panel | <1% | 168 | $15K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,415 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 213 | $14K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,640 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 248 | $13K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 617 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 541 | $10K |
| 84484 | <1% | 2,207 | $9K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 42 | $9K |
| 80061 | Lipid panel | <1% | 1,398 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 381 | $7K |
| 85730 | <1% | 2,676 | $7K | |
| 81001 | <1% | 3,485 | $6K | |
| 83735 | <1% | 2,277 | $6K | |
| 85610 | <1% | 2,819 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 559 | $5K |
| 83690 | <1% | 1,860 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,033 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 964 | $4K |
| 82150 | <1% | 1,304 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 772 | $3K |
| 83605 | <1% | 743 | $3K | |
| 87430 | <1% | 180 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 66 | $2K |
| 83880 | <1% | 136 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 701 | $2K |
| 87040 | <1% | 667 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 382 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 128 | $2K |
| 81025 | <1% | 296 | $2K | |
| 84439 | <1% | 209 | $1K | |
| 87400 | <1% | 76 | $1K | |
| 81003 | <1% | 1,764 | $1K | |
| 82550 | <1% | 593 | $1K | |
| 87807 | <1% | 73 | $737.53 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 136 | $575.60 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $564.22 |
| 85027 | <1% | 120 | $454.72 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 16 | $421.08 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $421.08 |
| 85379 | <1% | 68 | $399.14 | |
| 82553 | <1% | 341 | $383.36 | |
| 82607 | <1% | 33 | $285.61 | |
| 84481 | <1% | 20 | $231.48 | |
| 86800 | <1% | 20 | $218.09 | |
| 84432 | <1% | 19 | $203.98 | |
| 86376 | <1% | 20 | $200.41 | |
| 86803 | <1% | 17 | $185.51 | |
| 84482 | <1% | 18 | $184.62 | |
| 82077 | <1% | 21 | $138.16 | |
| 82728 | <1% | 17 | $110.50 | |
| 81000 | <1% | 80 | $57.12 | |
| 80069 | <1% | 17 | $43.03 | |
| 85007 | <1% | 24 | $26.38 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 383 | $3.94 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 400 | $3.83 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 177 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 194 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 421 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 293 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 44 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 90 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 856 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 71 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 42 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 327 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 47 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.